Researcher.Life Logo

Advances in Pharmacology : Impact Factor & More

eISSN: 1557-8925pISSN: 1054-3589

Key Metrics

CiteScore
8.3
SNIP
0.89
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Advances in Pharmacology

Advances in Pharmacology Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
Overview
Publisher Elsevier

Planning to publish in Advances in Pharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Advances in Pharmacology

Game changer: Navigating between challenges and hopes in geropharmacology.
  • 1 Jan 2025
  • Advances in pharmacology (San Diego, Calif.)
Targeting PAAN/MIF nuclease activity in parthanatos-associated brain diseases.
  • 1 Jan 2025
  • Advances in pharmacology (San Diego, Calif.)
Pharmacological frontiers in senescence: Transforming senescence with drug repurposing.
  • 1 Jan 2025
  • Advances in pharmacology (San Diego, Calif.)
Inhibition of brain glutamate carboxypeptidase II (GCPII) to enhance cognitive function
  • 1 Jan 2025
  • Advances in Pharmacology
Biological and therapeutic significance of targeting NLRP3 inflammasome in the brain and the current efforts to develop brain-penetrant inhibitors
  • 1 Jan 2025
  • Advances in Pharmacology
ADMET tools in the digital era: Applications and limitations.
  • 1 Jan 2025
  • Advances in pharmacology (San Diego, Calif.)
Game changer: Navigating between challenges and hopes in geropharmacology.
  • 1 Jan 2025
  • Advances in pharmacology (San Diego, Calif.)
Targeting PAAN/MIF nuclease activity in parthanatos-associated brain diseases.
  • 1 Jan 2025
  • Advances in pharmacology (San Diego, Calif.)
Pharmacological frontiers in senescence: Transforming senescence with drug repurposing.
  • 1 Jan 2025
  • Advances in pharmacology (San Diego, Calif.)
Inhibition of brain glutamate carboxypeptidase II (GCPII) to enhance cognitive function
  • 1 Jan 2025
  • Advances in Pharmacology
Biological and therapeutic significance of targeting NLRP3 inflammasome in the brain and the current efforts to develop brain-penetrant inhibitors
  • 1 Jan 2025
  • Advances in Pharmacology
ADMET tools in the digital era: Applications and limitations.
  • 1 Jan 2025
  • Advances in pharmacology (San Diego, Calif.)

FAQs on Advances in Pharmacology